Number of the records: 1  

alemtuzumab

  1. Topical termalemtuzumab
    See linkCampath (UF)
    Campath 1G (UF)
    Campath 1H (UF)
    Campath 1M (UF)
    Campath-1-G (UF)
    Campath-1G (UF)
    Campath-1H (UF)
    Campath-1M (UF)
    Lemtrada (UF)
    MabCambath (UF)
    Monoclonal Antibody Campath-1H (UF)
    See alsohumanizované monoklonální protilátky
    antigen CD52 (RT)
    protinádorové látky imunologicky aktivní (PA)
    Linking entryAlemtuzumab
    ConspectD12. - 776. - 124. - 486. - 485. - 114. - 224. - 060. - 313
    D12. - 776. - 124. - 790. - 651. - 114. - 224. - 060. - 375
    D12. - 776. - 377. - 715. - 548. - 114. - 224. - 200. - 375
    NoteAn anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.
    DatabaseMESH
    References (1) - MESH
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all